NovaBay Pharmaceuticals Inc. (AMEX:NBY) Is Down -27.37% Over The Past 30 Days: Could Trouble Be Ahead? – Marketing Sentinel
Home  »  Business   »  NovaBay Pharmaceuticals Inc. (AMEX:NBY) Is Down -2...

NovaBay Pharmaceuticals Inc. (AMEX:NBY) Is Down -27.37% Over The Past 30 Days: Could Trouble Be Ahead?

In last trading session, NovaBay Pharmaceuticals Inc. (AMEX:NBY) saw 1.32 million shares changing hands with its beta currently measuring 3.46. Company’s recent per share price level of $0.34 trading at -$0.04 or -8.48% at ring of the bell on the day assigns it a market valuation of $15.71M. That closing price of NBY’s stock is at a discount of -426.47% from its 52-week high price of $1.79 and is indicating a discount of -2.94% from its 52-week low price of $0.35. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.76 million shares which gives us an average trading volume of 929.71K if we extend that period to 3-months.

For NovaBay Pharmaceuticals Inc. (NBY), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.05 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

NovaBay Pharmaceuticals Inc. (AMEX:NBY) trade information

Upright in the red during last session for losing -8.48%, in the last five days NBY remained trading in the red while hitting it’s week-highest on Friday, 01/07/22 when the stock touched $0.34 price level, adding 13.31% to its value on the day. NovaBay Pharmaceuticals Inc.’s shares saw a change of -8.87% in year-to-date performance and have moved -8.09% in past 5-day. NovaBay Pharmaceuticals Inc. (AMEX:NBY) showed a performance of -27.37% in past 30-days. Number of shares sold short was 2.08 million shares which calculate 1.89 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $3.10 to the stock, which implies a rise of 89.03% to its current value. Analysts have been projecting $2.20 as a low price target for the stock while placing it at a high target of $4.00. It follows that stock’s current price would drop -1076.47% in reaching the projected high whereas dropping to the targeted low would mean a loss of -547.06% for stock’s current value.

NovaBay Pharmaceuticals Inc. (NBY) estimates and forecasts

Statistics highlight that NovaBay Pharmaceuticals Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -40.45% of value to its shares in past 6 months, showing an annual growth rate of 32.26% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to decrease by -25.00% in the current quarter and calculating 50.00% increase in the next quarter. This year revenue growth is estimated to fall -8.10% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $3.34 million for the same. And 2 analysts are in estimates of company making revenue of $4.03 million in the next quarter that will end on Mar 2022. Company posted $1.89 million and $2.34 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 76.90% while estimating it to be 72.20% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 45.90% during past 5 years.

NBY Dividends

NovaBay Pharmaceuticals Inc. is more likely to be releasing its next quarterly report between March 23 and March 28 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

NovaBay Pharmaceuticals Inc. (AMEX:NBY)’s Major holders

Insiders are in possession of 21.10% of company’s total shares while institution are holding 2.65 percent of that, with stock having share float percentage of 3.36%. Investors also watch the number of corporate investors in a company very closely, which is 2.65% institutions for NovaBay Pharmaceuticals Inc. that are currently holding shares of the company. Vanguard Group, Inc. (The) is the top institutional holder at NBY for having 0.49 million shares of worth $0.31 million. And as of Sep 29, 2021, it was holding 1.08% of the company’s outstanding shares.

The second largest institutional holder is Bridgeway Capital Management, Inc., which was holding about 0.15 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 0.34% of outstanding shares, having a total worth of $99587.0.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, Vanguard Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 0.37 million shares of worth $0.24 million or 0.83% of the total outstanding shares. The later fund manager was in possession of 0.15 million shares on Sep 29, 2021, making its stake of worth around $99587.0 in the company or a holder of 0.34% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam